Our MD program provides students with the tools and training to be ... Course The T2C course reinforces both the oral presentation and clinical skills needed in hands-on care of patients throughout ...

The Company believes IMC-R117C is the first PIWIL1-targeted immunotherapy and estimates that there are up to 20,000 colorectal cancer patients globally that are positive for both PIWIL1 and ...

The new PET-CT scan of UP PGH ... UP-PGH’s capabilities from basic healthcare to advanced medical interventions that have benefited poor patients in particular. “A market vendor in Paco ...

Colon cancer rates are surging worldwide, especially among younger and relatively healthy people, making it more important ...

The University of the Philippines-Philippine General Hospital (UP-PGH) recently acquired advanced diagnostic equipment and critical ... This ensures more comprehensive diagnostics. In addition, a new ...

Drs Kathy Miller and Francisco J. Esteva discuss testing and therapeutic options for the new classification of HER2-ultra-low breast cancer.

Yale researchers have made an unexpected discovery—turncoat T cells that help a tumor evade other cancer-fighting immune T cells—in a study of patients living with advanced melanoma.

There's new hope for people battling advanced bladder cancer who do not ... complete remission of the cancer in three-quarters of patients who hadn't responded to an immune-focused treatment ...

Patient experience encompasses the range of interactions that patients have with the healthcare system, including their care from health plans, and from doctors, nurses, and staff in hospitals, ...

The Phase 1/2 trial will assess the safety and clinical activity of IMC-R117C, as a monotherapy and in combination with standards of care, in patients with advanced cancers expressing PIWIL1 ...